WASHINGTON, Nov. 13, 2019 /PRNewswire/ -- Danaher Corporation
(NYSE: DHR) announced today that it has appointed Jessica L. Mega, MD, MPH and Pardis C. Sabeti, MD, D.Phil to its Board
of Directors.
Dr. Mega is currently Chief Medical and Scientific Officer of
Verily Life Sciences LLC, an Alphabet, Inc. company, where she has
served since March 2015. Prior to
joining Verily, she served as Cardiologist and Senior Investigator
at Brigham & Women's. Dr. Mega has also served as a faculty
member at Harvard Medical School and a
senior investigator with the TIMI Study Group, where she helped
lead international trials evaluating novel cardiovascular therapies
and directed the genetics program.
Dr. Mega is a graduate of Stanford
University, Yale University School of
Medicine and Harvard School of Public
Health. She completed her Internal Medicine Residency at
Brigham and Women's Hospital and Cardiovascular Fellowship at
Massachusetts General Hospital. She is
board certified in Internal Medicine and Cardiology and has won the
Laennec Society, Samuel A. Levine,
and Douglas P. Zipes Awards. Dr. Mega is also a Fellow of the
American Heart Association (AHA) and the American College of
Cardiology (ACC).
Dr. Sabeti is currently an Investigator for Howard Hughes
Medical Institute, a non-profit medical research organization,
where she has served since November
2015. Dr. Sabeti is a professor at both the Center for
Systems Biology and the Department of Organismic and Evolutionary
Biology at Harvard University and the
Department of Immunology and Infectious Disease at Harvard School of Public Health. She is also a
Broad Institute Member and a leader in the Broad's Infectious
Disease and Microbiome Program.
Dr. Sabeti is a graduate of the Massachusetts Institute of Technology, University of Oxford (as a Rhodes Scholar) and
Harvard Medical School. She is a World
Economic Forum Young Global Leader and a National Geographic
Emerging Explorer. In 2014, she was named a TIME magazine "Person
of the Year" as one of the Ebola fighters and in 2015 as one of
TIME's "100 Most Influential People." Her awards include the 2012
Smithsonian American Ingenuity Award for Natural Science, an
Ellis Island Medal of Honor, and the
2017 Richard Lounsbery Award from the National Academy of
Sciences.
Steven M. Rales, Chairman of the Board of Danaher Corporation,
said "We are very pleased to welcome Drs. Mega and Sabeti to the
Danaher Board of Directors. Their inspiring and diverse expertise
in some of the most promising areas of science will provide
valuable insights to Danaher as we continue to live our Shared
Purpose, Helping Realize Life's Potential."
About Danaher
Danaher is a global science and
technology innovator committed to helping its customers solve
complex challenges and improving quality of life around the world.
Its family of world class brands has leadership positions in the
demanding and attractive health care, environmental and applied
end-markets. With more than 20 operating companies, Danaher's
globally diverse team of approximately 71,000 associates is united
by a common culture and operating system, the Danaher Business
System, and its Shared Purpose, Helping Realize Life's
Potential.
View original
content:http://www.prnewswire.com/news-releases/danaher-announces-appointment-of-jessica-l-mega-md-mph-and-pardis-c-sabeti-md-dphil-to-danaher-board-300957804.html
SOURCE Danaher Corporation